CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0
Read more about CPHI

Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg

Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg
Product Description

We have developed novel small capsules of marketed Dutasteride and Tamsulosin HCl Capsules (Jalyn/Duodart/Combodart)) for BPH indication. The marketed product is a big pill, 23mm in length above FDA’s recommendation (22mm). Large pill size of marketed product considered burdensome for patients; potentially causing difficulty swallowing* (Dysphagia) especially in elder population where BPH in more prevalent (80% Male at 80 Yr old). Our pill is 2/3 in size compared to marketed product and potentially solve the problem of swallowing, eventually drive patient compliance. 

The product development is completed and pilot BE study is in-progress. We are in-process of filing formulation patent.

Global market for Dutasteride in BPH is ~550M USD. Our plan is to launch this product globally. We are seeking partner for registration and global launch. 

Read more Show less

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Product Features; Product Performance; Patient centric drug delivery: Solve issue of swallowing difficulty (Dysphagia) of marketed product for elder patient and increase patient compliance 

  • Model
    Specialty Generic
  • Supplied from
    India; Korea, Republic Of
More specifications Fewer specifications
Sales Markets
Show more Show less

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
View company profile

More Products from YUYU PHARMA (3)

  • Calcitriol 1μg

    Product Calcitriol 1μg

    1. Efficacy & Effectiveness

    1) Treatment for hypocalcemia in chronic kidney dialysis patients.

    2) Improvement of skeletal dysplasia by remarkable reducing elevated parathyroid hormone levels.

    2. Administration & Dosage

    The initial recommend...
  • Dutasteride and Tadalafil Tablet 0.5/5 mg

    Product Dutasteride and Tadalafil Tablet 0.5/5 mg

    We have developed novel combination of marketed individual Dutasteride and Tadalafil (Avodart + Cialis) for BPH indication. The combination of tadalafil with dutasteride provide better therapeutic effect in improvement of BPH and LUTs symptoms while reduce adverse effect profile particularly Erectile d...
  • Dutasteride Tablet 0.5 mg

    Product Dutasteride Tablet 0.5 mg

    We have developed novel small tablet of marketed Dutasteride Softgel (Avodart) for BPH and acute urinary retention indication. This small pill will help to resolve swallowing difficulties in elder population where BPH in more prevalent (80% Male at 80 Yr old).

    The product development...